Video: NeuroPointDX Presents at TACA East Coast 2019
Metabolism Based Diagnosis and Precision Medicine for Autism Spectrum Disorders
Presented at The National TACA Autism Conference – East Coast in Atlanta, Georgia, March 2019.
Behavioral tests can lead to an ASD diagnosis in children as young as 24 months old, but the average age of diagnosis in the United States is more than 4 years!
Being told to “wait and see” can be frustrating for parents. It’s tough to wait it out when your child needs help.
The NeuroPointDX test offers an opportunity to identify and refer children at risk of an autism diagnosis earlier so they can receive treatment sooner.
As the parents of an adult son on the spectrum, Beth Donley, who helped develop the test, knows firsthand how important receiving an early diagnosis and a precise treatment plan is to helping our children reach their potential. This knowledge was the motivation behind her quest to develop a test that can diagnose children with autism as early as 18 months.
In this video, Beth shares a little about her history as an autism mom as well as details about the NeuroPointDX ASD test, which is a blood test that can identify about 30% of children with autism spectrum disorder with an increased risk of an ASD diagnosis. This means that 3 in 19 kids with autism spectrum disorder could receive an earlier diagnosis, get interventions sooner, and potentially receive more precise treatment suggestions from their doctors, based on the information about their own metabolism.
Adapted from a post on @TheAutismCommunityinAction Facebook page.
- RT @ASDMentalHealth: Research Summaries of Studies on Managing Anxiety in the Classroom - Autism Mental Health Blog https://t.co/oByYtNSCQM…5 hours ago
- For a quick overview of the #NPDX #ASD test, read our brochure. Print it out and bring it to your next appointment… https://t.co/kMfhnHBBs46 hours ago
- RT @TACAfoundation: You've got this! #AutismTough Keep on keeping ON https://t.co/XDmxg4OVyS https://t.co/lSpCRnaEl25 days ago